Evaluation of the safety and immunogenicity of different covid-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [pribivac]

HIGHLIGHTS

• who: Xuan Ying Poh from the School, SingaporeLee Kong Chian School of Medicine, Nanyang Technological University have published the paper: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC], in the Journal: (JOURNAL) of 17/01/2022
• what: The aims of this phase 3 subject-blinded controlled clinical trial are to assess the safety and immunogenicity of heterologous boost COVID-19 vaccine regimens (intervention groups 1-4) compared with homologous boost regimen (control arm) in up to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.